ASP2408
/ Astellas, Maxygen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 01, 2013
Financial results for 2Q/FY 2013 ending March 31, 2014
(Astellas Press Release)
- ASP2408 discontinued in rheumatoid arthritis due to strategic reasons.
Discontinued • Immunology • Rheumatoid Arthritis
1 to 1
Of
1
Go to page
1